Text segments describing renal outcomes, mechanisms, or subgroup effects were coded and clustered into thematic categories (e.g., early intervention and kidney protection, CKD progression attenuation, cardiorenal benefit beyond glycemia)
Overall, a new era in obesity care is starting, as multiple effective obesity pharmacotherapies with different mechanisms of action and routes of administration may become available over next years
Here are the results: If I understand correctly, at some point 6 out of the 24 subjects in the placebo group stopped providing these records, and 3 out of 24 in the semaglutide group
iNKT cell modulation, AMPK phosphorylation, IL-23/Th17 regulation, and reduction of T cells have all shown to be possible mechanisms by which GLP-1RAs exert anti-inflammatory effects
More Than Just a Cleanser A Skin Transformation
Quite a few things, split between how you live your life and your biology